Apigenin blocks IKKα activation and suppresses prostate cancer progression

IKKα has been implicated as a key regulator of oncogenesis and driver of the metastatic process; therefore is regarded as a promising therapeutic target in anticancer drug development. In spite of the progress made in the development of IKK inhibitors, no potent IKKα inhibitor(s) have been identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Sanjeev, Kanwal, Rajnee, Shankar, Eswar, Datt, Manish, Chance, Mark R., Fu, Pingfu, MacLennan, Gregory T., Gupta, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741599/
https://www.ncbi.nlm.nih.gov/pubmed/26435478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741599/
https://www.ncbi.nlm.nih.gov/pubmed/26435478

Ejemplares similares